Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
- سال انتشار: 1398
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 22، شماره: 12
- کد COI اختصاصی: JR_IJBMS-22-12_012
- زبان مقاله: انگلیسی
- تعداد مشاهده: 291
نویسندگان
School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, China
School of Public Health, Xi’an Jiaotong University, Xi’an, Shaanxi, China
School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, China
School of Pharmacy, Xi’an Jiaotong University, Xi’an, Shaanxi, China
چکیده
Objective(s): This study is aimed to design and synthesize a prodrug of 5-aminosalicylic acid and evaluate its ameliorative effect on experimental ulcerative colitis (UC).Materials and Methods: 5-Aminosalicylic acid-alanine (5-ASA-ALA) was synthesized and characterized. Its stability study was conducted in rat plasma and in the gastrointestinal tract environment, its transport characteristic was assessed using the Caco-2 cells. Its colon-targeting property was evaluated by the pharmacokinetic study, and incubation studies. A series of indicators were used to investigate its therapeutic effect on experimental colitis, including the survival rate and body weight of mice, the disease activity index (DAI), the colonic damage score and colon index, the myeloperoxidase (MPO) activity and the levels of malondialdehyde (MDA), total superoxide dismutase (SOD), glutathione (GSH) and glutathione peroxidase (GSH-Px) in colonic tissues.Results: 5-ASA-ALA was barely absorbed in the Caco-2 monolayer or into the rat blood. It was remarkably stable when incubated in the upper gastrointestinal tract, while gradually hydrolyzed in the colon of rats. When orally administered to mice, 5-ASA-ALA had significantly greater therapeutic effect on colitis than the positive control. Conclusion: 5-ASA-ALA is demonstrated to be a promising oral colon-targeting prodrug of 5-ASA and has potential application in UC treatment.کلیدواژه ها
Anti-inflammation, Colon targeting, Prodrug, Ulcerative colitis, 5-Aminosalicylic acidاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.